SALUBRIS - Trademark Details
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Serial Number
79083827
Registration Number
3972681
Word Mark
SALUBRIS
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2020-05-12
Filing Date
2010-05-11
Registration Number
3972681
Registration Date
2011-06-07
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2011-03-22
Law Office Assigned Location Code
M60
Employee Name
POVARCHUK, REBECCA JOY
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; chemico-pharmaceutical preparations, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; chemical preparations for pharmaceutical purposes, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; medicines for human purposes, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; troches, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; pharmaceutical products, namely, active pharmaceutical ingredients which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; prepared Chinese medicines, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; biochemical medicines, namely, for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; dietetic substances adapted for medical use, namely, beverages or food which are used for treating diseases of cardiovascular system, for use in hematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; capsules for pharmaceutical purposes containing pharmaceutical preparations, specifically for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; drugs for medical purposes, namely, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2018-10-12
Primary Code
005
Correspondences
Name
SHENZHEN SALUBRIS PHARMACEUTICALS CO., L
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1042230
International Registration Date
2010-05-11
International Publication Date
2010-07-22
International Renewal Date
2020-05-11
Auto Protection Date
2012-01-15
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2020-05-12
Priority Claimed In
False
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2010-07-15 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2010-07-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2010-07-23 | APPLICATION FILING RECEIPT MAILED |
| 2010-08-24 | ASSIGNED TO EXAMINER |
| 2010-08-24 | NON-FINAL ACTION WRITTEN |
| 2010-08-25 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2010-08-25 | REFUSAL PROCESSED BY MPU |
| 2010-08-25 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2010-09-18 | REFUSAL PROCESSED BY IB |
| 2011-01-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2011-01-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2011-01-19 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2011-01-19 | EXAMINERS AMENDMENT -WRITTEN |
| 2011-01-19 | EXAMINER'S AMENDMENT ENTERED |
| 2011-01-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2011-01-20 | CORRESPONDENCE MAILED |
| 2011-02-11 | ASSIGNED TO LIE |
| 2011-02-16 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2011-03-02 | NOTICE OF PUBLICATION |
| 2011-03-03 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2011-03-03 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2011-03-22 | PUBLISHED FOR OPPOSITION |
| 2011-06-07 | REGISTERED-PRINCIPAL REGISTER |
| 2011-09-07 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2011-11-01 | FINAL DISPOSITION PROCESSED |
| 2011-11-01 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2013-02-25 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2017-12-06 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2017-12-06 | TEAS SECTION 71 RECEIVED |
| 2017-12-19 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2018-01-03 | POST REGISTRATION ACTION MAILED - SEC.71 |
| 2018-10-10 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2018-10-12 | CANCELLED SECTION 71 |
| 2019-06-12 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 2019-07-01 | GENERIC MADRID TRANSACTION CREATED |
| 2019-07-01 | GENERIC MADRID TRANSACTION SENT TO IB |
| 2019-09-27 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 2020-12-04 | DEATH OF INTERNATIONAL REGISTRATION |
| 2020-12-04 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
